Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

JAMA Ophthalmology

JAMA Ophthalmology Opinion EDITORIAL It’s Not Just a New Name Neil M. Bressler, MD The world of ophthalmology is fortunate to have had the schol- not too much time. Readers should expect new content start- arly leadership of Daniel Albert, MD, MS, as one of the longest- ing in 2014. This content will be meant to enhance the cutting- serving editors of JAMA Ophthalmology, formerly the Archives edge clinical research publications. Readers should antici- of Ophthalmology. It is an honor and a privilege for me to fol- pate expanded sections on viewpoints and perspectives that low Dr Albert as the next (and ninth) editor of JAMA Ophthal- discuss how one might consider applying new evidence from mology. Far beyond just a new editor in chief, this July 2013 clinical trials into everyday practice. An illustrious group of con- issue begins the transition to a major redesign coordinated tributing writers from the ophthalmic branches of the US Food with JAMA and the 9 specialty journals, including JAMA and Drug Administration, the National Institutes of Health, and Ophthalmology, that represent The JAMA Network. Asare- the Cochrane Collaboration will provide commentaries of con- sult of these changes, and the tight bond of The JAMA http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

JAMA Ophthalmology

JAMA Ophthalmology , Volume 131 (7) – Jul 1, 2013

JAMA Ophthalmology

Abstract

Opinion EDITORIAL It’s Not Just a New Name Neil M. Bressler, MD The world of ophthalmology is fortunate to have had the schol- not too much time. Readers should expect new content start- arly leadership of Daniel Albert, MD, MS, as one of the longest- ing in 2014. This content will be meant to enhance the cutting- serving editors of JAMA Ophthalmology, formerly the Archives edge clinical research publications. Readers should antici- of Ophthalmology. It is an honor and a privilege for...
Loading next page...
 
/lp/american-medical-association/jama-ophthalmology-uHSJkox7CS
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2013.5420
pmid
23846200
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL It’s Not Just a New Name Neil M. Bressler, MD The world of ophthalmology is fortunate to have had the schol- not too much time. Readers should expect new content start- arly leadership of Daniel Albert, MD, MS, as one of the longest- ing in 2014. This content will be meant to enhance the cutting- serving editors of JAMA Ophthalmology, formerly the Archives edge clinical research publications. Readers should antici- of Ophthalmology. It is an honor and a privilege for me to fol- pate expanded sections on viewpoints and perspectives that low Dr Albert as the next (and ninth) editor of JAMA Ophthal- discuss how one might consider applying new evidence from mology. Far beyond just a new editor in chief, this July 2013 clinical trials into everyday practice. An illustrious group of con- issue begins the transition to a major redesign coordinated tributing writers from the ophthalmic branches of the US Food with JAMA and the 9 specialty journals, including JAMA and Drug Administration, the National Institutes of Health, and Ophthalmology, that represent The JAMA Network. Asare- the Cochrane Collaboration will provide commentaries of con- sult of these changes, and the tight bond of The JAMA

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Jul 1, 2013

References